Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mouth Neoplasms × Epinephrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 3 Breast Neoplasms 3 Stomach Neoplasms 2 Pain 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Supratentorial Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Postoperative Hemorrhage 1 Polyposis, Gastric 1 Oropharyngeal Neoplasms 1 Nerve Block 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Musculoskeletal Diseases 1 Multiple Myeloma 1 Mouth Neoplasms 1 Malignant Neoplasms of Male Genital Organs 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Hairy Cell 1 Leukemia 1 Leiomyoma 1 Hypotension 1 Hodgkin Disease 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 27 Magnetic Resonance Spectroscopy 20 pembrolizumab 16 Specimen Handling 16 Radiotherapy 16 Cetuximab 15 Biopsy 13 Radiotherapy, Intensity-Modulated 12 Paclitaxel 10 Fluorouracil 10 Carboplatin 10 Radiation 9 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Surveys and Questionnaires 7 Surgical Procedures, Operative 7 Drug Therapy 7 X-Rays 6 Taxes 6 Standard of Care 6 Celecoxib 6 Sentinel Lymph Node Biopsy 5 Observation 5 Nivolumab 5 Metformin 4 Interviews as Topic 4 Immunohistochemistry 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Chemoradiotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01418118 2011-08-16

Free4Flow

Oxford University Hospitals NHS Trust

Phase 4 Completed

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡